TABLE 4

Kinase inhibition data showing percentage kinase activity in the presence of 10 µM ANI-7

Data represent the mean ± S.E.M. of duplicate experiments.

Kinase Classification
ReceptorsPhosphatidylinositol 3-kinase (PI3K)/mTOR pathway
 EGFR101 ± 1a PDK1/PDPK195 ± 1.4a
 ERBB2/HER295 ± 3a SGK195 ± 0.8a
 ERBB4/HER4102 ± 6a SGK293 ± 1.1a
 IGF1R90 ± 7.2b SGK3/SGKL99 ± 3.1a
 PDGFRa87 ± 8.5a AKT194 ± 2.3a
 PDGFRb102 ± 2.3a AKT291 ± 1.9a
Lipid kinases AKT3104 ± 2.0a
 Choline kinase α97 ± 2.4b COT1/MAP3K895 ± 0.8a
 Choline kinase β97 ± 4.1b GSK3a80 ± 0.3a
 DGKβ93 ± 30b GSK3b89 ± 1.5a
 DGKγ83 ± 20b mTOR/FRAP198 ± 0.7a
 DGKζ88 ± 14b ROCK195 ± 2.3a
 PI3Kα84 ± 1.9a ROCK298 ± 0.3a
 PI3Kβ95 ± 6.9a P70S6K103 ± 3.0b
 PI3Kδ77 ± 8.3aMitogen-activated protein kinase pathway
 PI3Kγ66 ± 12a RAF1106 ± 1.3a
 PI4K2A94 ± 8.4b ARAF100 ± 2.3a
 PIP5K2A83 ± 0.6b BRAF101 ± 1.2a
 Sphingosine kinase 165 ± 23b MEK1101 ± 1.5a
 Sphingosine kinase 280 ± 8.9b MEK292 ± 0.3a
Others ERK1100 ± 1.6a
 BRK91 ± 4.6a ERK2/MAPK198 ± 0.7a
 PKBa101 ± 0.2b c-Src87 ± 4.6a
 PKD1119 ± 0.1b
 PKBb99 ± 9.0b
  • a Reaction Biology Corporation, Malvern, PA.

  • b The International Centre for Kinase Profiling, University of Dundee, UK.